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ABSTRACT
Recurrent relapse is a major problem in treating opiate addiction. Pavlovian conditioning plays a role in recurrent re-
lapse whereby exposure to cues learned during drug intake can precipitate relapse to drug taking. α7 nicotinic acetyl-
choline receptors (nAChRs) have been implicated in attentional aspects of cognition and mechanisms of learning and
memory. In this study we have investigated the role of α7 nAChRs in morphine-conditioned place preference (mor-
phine-CPP). CPP provides a model of associative learning that is pertinent to associative aspects of drug dependence.
The α7 nAChR antagonist methyllycaconitine (MLA; 4 mg/kg s.c.) had no effect on the acquisition, maintenance,
reconsolidation or extinction of morphine-CPP but selectively attenuated morphine-primed reinstatement of CPP, in
both mice and rats. Reinstatement of morphine-CPP in mice was accompanied by a selective increase in [3H]-AMPA
binding (but not in [3H]-MK801 binding) in the ventral hippocampus that was prevented by prior treatment with
MLA. Administration of MLA (6.7 μg) directly into the ventral hippocampus of rats prior to a systemic priming dose
of morphine abolished reinstatement of morphine-CPP, whereas MLA delivered into the dorsal hippocampus or prefron-
tal cortex was without effect. These results suggest that α7 nAChRs in the ventral hippocampus play a speciﬁc role
in the retrieval of associative drug memories following a period of extinction, making them potential targets for the
prevention of relapse.
Keywords [3H]-AMPA, [3H]-MK801, autoradiography, intracerebral drug delivery, methyllycaconitine.
Correspondence to: Sue Wonnacott, Department of Biology & Biochemistry, University of Bath, Bath BA2 7AY. E-mail: bsssw@bath.ac.uk
INTRODUCTION
Drug addiction is a chronic relapsing brain disorder
(Leshner 1997; Koob & Volkow 2010), with relapse pos-
ing the greatest obstacle to overcoming addiction. For ex-
ample, almost 3 million people in the United States are
estimated to be addicted to prescription opiates or heroin
(National Survey on Drug Use and Health, 2013;
Lyapustina & Alexander 2015). Despite the availability
of substitution products such as methadone, relapse to
heroin use is prevalent. Relapse may be triggered by a
variety of stimuli including drug-associated cues, expo-
sure to sub-threshold (priming) doses of drug or stress
(Shalev, Grimm, & Shaham 2002). Understanding the
brain mechanisms underlying the different stages of drug
addiction may identify novel targets for intervention.
The cholinergic system is intimately engaged with re-
ward circuitry in the brain. Nicotine, acting through nic-
otinic acetylcholine receptors (nAChRs) within these
circuits, sustains tobacco addiction (Wonnacott,
Sidhpura, & Balfour 2005; Brunzell, Stafford, & Dixon
2015), which commonly co-exists with the use of other
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addictive substances. Indeed, tobacco smoking has been
regarded as a gateway to illicit drug use (Jessup 1996;
Kandel & Kandel 2015). Physiologically, nAChRs mediate
the actions of endogenous acetylcholine, which is impli-
cated in attention (notably to cues that prompt goal-
directed behaviours), motivation and learning and mem-
ory, important facets of addiction (Luchicchi et al. 2014;
Sarter et al. 2014). Thus, nAChRs may contribute to gen-
eral processes underlying drug dependence and nAChRs
have been proposed as novel targets for treating addiction
(Rahman, Engleman, & Bell 2015).
The α7 nAChR, which is highly expressed in the hippo-
campus and cortex (Yakel 2014), has gained prominence
for its association with attentional aspects of cognition
and mechanisms of learning and memory (Levin, Hall, &
Rezvani 2015). In the present experiments, we sought
to investigate the contribution of α7 nAChRs to opiate re-
ward, using the conditioned place preference (CPP) model
of motivational learning, with morphine as the uncondi-
tional stimulus. This model is well established (Bardo &
Bevins 2000; Tzschentke 2007; Aguilar, Rodríguez-Arias,
& Miñarro 2009) and allows acquisition, maintenance,
extinction and reinstatement of drug-seeking behaviour
to be interrogated. A previous report (Feng et al. 2011)
has implicated α7 nAChRs in morphine-primed reinstate-
ment of CPP in mice, but other components of morphine-
seeking behaviour were not examined. Therefore, we
have used the selective antagonist methyllycaconitine
(MLA), delivered systemically and intracerebrally, to block
α7 nAChRs at different stages of morphine-CPP. Changes
in glutamate receptor density were monitored in parallel,
using quantitative autoradiography, in order to shed light
into the possible mechanisms underlining these effects.
This study has revealed a selective action of α7 nAChR an-
tagonism in the ventral hippocampus that inhibits both
morphine-primed CPP and associated increases in AMPA
receptor binding in this brain region.
MATERIALS AND METHODS
Animals
Male C57BL/6 mice (6–7 weeks of age at the start of
experiments; Charles River, Kent, UK) and Wistar rats
(400 g, University of Bath breeding colony) were housed
in groups of four, except following surgery when
rats were singly housed, in a controlled environment
[12:12 hour light–dark cycle (lights on 07:00); constant
temperature (24 ± 2°C) and humidity (55 ± 5%)]. Food
and water were available ad libitum. Animals were han-
dled daily for 1 week prior to the start of experiments.
All experiments were approved by the UK Home Ofﬁce
and performed in accordance with UK Animals (Scientiﬁc
Procedures) Act of 1986 and conform to the Animals in
Research: Reporting In Vivo Experiments (ARRIVE)
guidelines (Kilkenny et al. 2010).
Drugs
Morphine hydrochloride was purchased from MacFarlan
Smith, Edinburgh, UK; MLA was purchased from Tocris
Cookson, Avonmouth, UK. For peripheral administration,
drugs were dissolved in sterile saline and injected in a
volume of 10 ml/kg. Control animals received vehicle
injections (sodium chloride 0.9% w/v, Hameln
Pharmaceuticals, Gloucester, UK). For intracerebral
injections, MLA (2.8 mg/ml) was dissolved in saline.
[3H]-(+)-MK801 (22.5 Ci/mmol) and [3H]-AMPA
(58.1 Ci/mmol) were from Perkin Elmer Life Sciences,
USA. CNQX, (+)-MK801 and all other reagents were
from Sigma, Poole, Dorset, UK.
Conditioned place preference procedure
Conditioned place preference (CPP) was carried out essen-
tially as previously described (Ribeiro Do Couto et al.
2003; Cordery et al. 2014). Mouse CPP was in two-
compartment shuttle boxes (Ugo Basile, Gemonio, Italy).
Compartments were 15 cm square; one compartment
consisted of grey walls and a metal ﬂoor with circular
holes, the other had striped walls and square holes. Rat
CPP was in three-compartment shuttle boxes (Tracksys,
Nottingham, UK). Compartments were 40 cm square,
linked via a 10-cm square central area; one compartment
consisted of horizontal black and white stripes and ametal
ﬂoor with circular holes, the other had vertical black and
white stripes and a metal ﬂoor with square holes.
Experiments were performed between 08:00 and
17:00 under dim white light (light intensity approxi-
mately 15 lux). During all preference test sessions
(typically 15 minutes), the animal had free access to both
compartments; the time each animal spent in each com-
partment and their locomotor activity (distance travelled)
was recorded using EthoVision XT version 8.0 (Tracksys)
tracking software.
Acquisition of morphine-conditioned place preference
Following drug-free habituation trials (1 × 15-minute
session/day for 2 days, with free access to both compart-
ments) to reveal any innate preference for either of the
compartments, animals were pseudorandomly assigned
to treatment groups that were organized so that mean
baseline preferences for a particular compartment were
close to zero (Fig. 1a). Morphine conditioning consisted
of 1 × 40-minute trial/day for 4 days, starting 2 days af-
ter the habituation test. Each animal was conﬁned to one
compartment following injection of morphine (mice:
10 mg/kg i.p.; rats 5 mg/kg s.c.) or saline. The
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Figure 1 Effect of MLA on stages of morphine-CPP in C57BL/6 mice. (a) Acquisition. Mice were tested for any innate preference for a par-
ticular chamber (Habituation) and then pseudo-randomly allocated to two groups with comparable mean preference scores. The MLA group
received MLA (4 mg/kg) 20 minutes prior to a conditioning dose of morphine (10 mg/kg) or saline, paired with alternative compartments, on 4
consecutive days. The control group received saline instead of MLA. A preference test was conducted on the next day, giving the animals free
access to both compartments of the CPP apparatus for 15 minutes. Preference scores indicate the time spent in the morphine-paired compart-
ment in seconds minus 450 (half of the total time). Data are expressed as the mean ± S.E.M. Both groups showed signiﬁcant acquisition of mor-
phine-CPP (*saline: P< 0.05, **MLA: P < 0.005, n = 16 per group) indicating that MLA treatment had no effect on the acquisition of morphine-
CPP. (b) Maintenance. Mice were allocated to two groups and both groups were treated identically, to acquire morphine-CPP as in (a). They
were tested for expression of morphine-CPP on 5 consecutive days and 1 week later. One group received MLA (4 mg/kg) 20 minutes prior
to each preference test, the control group received saline instead of MLA. Both groups acquired morphine-CPP (**P< 0.005, n = 12 per group).
MLA treatment had no effect on the expression of morphine-CPP during the maintenance phase. (c) Schematic for reconsolidation and rein-
statement experiments. (d) Reconsolidation. Two groups of mice were treated identically, to acquire morphine-CPP as in (a). Three days later
mice received a further dose of morphine (10 mg/kg) in the drug-paired compartment. Immediately afterwards, one group received MLA (4 mg/
kg) while the control group received saline. The mice underwent a preference test the next day and one week later. Both groups acquired
morphine-CPP (**P < 0.005, n = 12 per group). Their preference for the drug-paired compartment was consolidated by morphine and unaf-
fected by MLA. E. Reinstatement. Two groups of mice were treated identically, to acquire morphine-CPP as in (a), followed by 4 days of extinc-
tion, (saline injections only, paired with alternative compartments) on separate days. Both groups acquired morphine-CPP (**P < 0.005, n = 20
per group) and this was attenuated following extinction training. On the following day, mice received a priming dose of morphine (5 mg/kg) prior
to an extended preference test (30 minutes); one group received MLA (4 mg/kg) 20 minutes before morphine; the control group received saline
instead of MLA. Only the control group of mice showed signiﬁcant reinstatement of morphine-CPP in contrast to MLA-treated mice (saline:
**P < 0.005). The time spent in the morphine-paired compartment was signiﬁcantly different between MLA and saline treatments
(†P < 0.005). MLA signiﬁcantly inhibited reinstatement of morphine-CPP
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drug/saline pairing and compartment were reversed on
consecutive days, so that each animal received two
morphine injections and two saline injections. A
counterbalanced design was employed such that within
a treatment group, half the animals were drug-paired
with one compartment type and the other half were
drug-paired with the other compartment type; the
order of morphine or saline presentation was also
counterbalanced. A drug-free post-conditioning prefer-
ence test was carried out 24 hour after the last drug
treatment. Animals were placed in the CPP box with free
access to both compartments for 15 minutes and time
spent in each compartment was recorded, to determine
their preferences. Saline-only controls were included in
a preliminary experiment to validate the established pro-
tocol (Fig. S1). Thereafter, all subjects received morphine
in the counterbalanced design described, to test the
effects of α7 nAChR antagonism.
To examine the effect of systemic MLA on morphine-
CPP acquisition, animals received MLA (4 mg/kg s.c.) or
saline 20 minutes before each conditioning dose of
morphine.
Maintenance of morphine-conditioned place preference
To assess whether MLA affected the maintenance of
morphine-CPP, animals were subjected to morphine con-
ditioning as described previously (Fig. 1b). Following the
post-conditioning preference test to establish that they
had acquired morphine-CPP, they were subjected to
additional preference tests over the following 4 days and
1 week later. MLA (4 mg/kg) or saline was given 20 mi-
nutes before each test.
Reconsolidation of morphine-conditioned place preference
Animals acquired morphine-CPP as described earlier
(Fig. 1d). Three days after the post-conditioning prefer-
ence test, all animals received morphine and were imme-
diately conﬁned to their drug-paired side of the CPP box
for 40 minutes (reconsolidation step). MLA (4 mg/kg)
or saline was administered at the end of this session, prior
to return to the home cage. A preference test was carried
out 1 day and 7 days later.
Extinction and reinstatement of morphine-conditioned place
preference
Animals acquired morphine-CPP, as described previously,
followed by extinction training (Figs 1e, 4 & 5). Animals
received saline injections only, paired with alternate com-
partments of the CPP box, over 4 consecutive days. On
the following day, the animals were subjected to another
preference test. Only those that met criterion (less than
70% of time spent in the previously drug-paired
compartment) were considered to show extinction and
proceeded to the reinstatement phase. Fewer than 5%
of subjects were excluded.
Three days later, for the reinstatement of morphine-
CPP, animals received a priming dose of morphine (mice:
5 mg/kg i.p.; rats 2.5 mg/kg s.c.) prior to being given an
extended preference test (30 minutes, based on a prelim-
inary experiment), with free access to both compart-
ments of the CPP box; the time spent in each
compartment was monitored over two 15 minutes bins.
Preliminary data showed development of reinstatement
over the 30-minute test session (as in Mueller, Perdikaris,
& Stewart 2002), therefore the second 15 minutes bin
was taken for reinstatement values. MLA (4 mg/kg s.c.)
or saline was administered 20 minutes before the priming
dose of morphine. In mice, saline-only controls were in-
cluded in a preliminary experiment to validate the
established protocol (Fig. S1). Reinstatement produced
more variable data sets, requiring a larger sample size
for statistical power.
Intracerebral cannula implantation and drug delivery
Bilateral cannulae were implanted into the medial PFC
(mPFC), ventral or dorsal hippocampus of 52 rats follow-
ing acquisition and extinction of morphine-CPP, but
prior to the reinstatement test. Rats were anaesthetized
with isoﬂurane (induction 4%, maintenance, 2–3%,
Baxter, UK), placed into a stereotaxic frame and guide
cannulae were implanted into the mPFC (coordinates
relative to bregma: anterior–posterior +3.2, medial–
lateral ±0.75, dorsal–ventral 2.8), the dorsal hippo-
campus (anterior–posterior 3.2, medial–lateral ±2.5,
dorsal–ventral 1.8) or ventral hippocampus (ante-
rior–posterior 5.3, medial–lateral ±5.2, dorsal–ventral
4.5). Dummy cannulae were inserted and secured
with a dust cap to prevent post-surgical infection. The
rats were rehydrated with 0.9% saline solution (10 ml/
kg s.c.) and were given an antibiotic (0.2 ml clamoxyl
LA, 150 mg/ml s.c.) and an analgesic (Caprieve,
5 mg/kg s.c). Animals were allowed to recover for 7 days.
Infusions were performed in conscious, gently re-
strained animals 15 minutes before the reinstatement
trial. MLA or saline (2.4 μl /hemisphere) was delivered
over 4 minutes (0.6 μl/min) via a 33 gauge infusion can-
nula, using an infusion pump (Harvard apparatus). The
cannulae were left in place for a further 4 minutes.
Infusions were conducted in pairs of animals.
To verify cannula placement, at the end of the experi-
ment, rats were killed by rising CO2 asphyxiation, and
0.5-ml brilliant blue dye was infused via each cannula,
using the infusion pump. Brains were frozen in
isopentane and stored at 80°C. Coronal sections were
made using a cryostat at 21°C. Sections containing
the dye marks were compared with a brain atlas (Paxinos
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& Watson 2007; Fig. S2). Three animals were culled due
to adverse reaction to surgery; no animals were excluded
following veriﬁcation of cannula placement.
Quantitative autoradiography
Twenty-four mice underwent morphine-CPP acquisition
followed by extinction training (Fig. 1c) and were then
randomly assigned to one of the four groups:
• Saline pretreatment/saline reinstatement (6)
• MLA pretreatment/saline reinstatement (6)
• Saline pretreatment/morphine-primed reinstatement
(6)
• MLA pretreatment/morphine-primed reinstatement
(6)
Animals were killed by cervical dislocation immedi-
ately after the reinstatement test, brains were frozen in
isopentane and stored at 80°C. Adjacent 20 μm coro-
nal sections were collected containing the prefrontal cor-
tex (bregma +1.94 mm), striatum (bregma +1.42 mm),
dorsal hippocampus (bregma 1.22 mm) and the mid-
brain/ventral hippocampus (bregma 3.08 mm; Paxinos
& Franklin 2012). Consecutive sections were freeze-thaw
mounted onto separate gelatin-subbed glass slides for
total and non-speciﬁc labelling and processed for autora-
diography as described previously (Kitchen et al. 1997).
N-methyl-d-aspartate receptor quantitative autoradiography
Slides were preincubated (20 minutes, 20°C) in 50 mM
Tris-HCl, pH 7.4, containing 50-μM glutamate, 50-μM
glycine and 50-μM spermidine. Subsequently, slides were
incubated (1 hour, 4°C) in the same buffer containing
70 nM [3H]-(+)-MK801 to determine total binding.
Non-speciﬁc binding was determined in the presence of
1 mM (+)-MK801 (Reynolds 2001). Slides were rinsed
twice for 30 seconds in ice-cold 50 mM Tris-HCl,
pH 7.4, followed by distilled water and rapidly dried with
a stream of cool air and placed in a sealed container with
anhydrous calcium sulphate for 1 week.
AMPA receptor quantitative autoradiography
AMPA receptors were labeled with [3H]-AMPA as previ-
ously described (Duncan et al. 2002). Slides were pre-
incubated (20 minutes, 20°C) in 50 mM Tris-HCl,
pH 7.4, containing 50 mM sodium thiocyanate. Total
binding was determined by incubating sections (45 mi-
nutes, 20°C) in the same buffer containing 10 nM [3H]-
AMPA. Non-speciﬁc binding was determined in adjacent
sections incubated in the additional presence of 0.1 mM
CNQX. Slides were rinsed three times for 20 seconds in
ice-cold 50 mM Tris-HCl, pH 7.4, followed by distilled wa-
ter and rapidly dried with a stream of cool air and stored
with anhydrous calcium sulphate as for [3H]-(+)-MK801
binding.
Slides were apposed to photographic ﬁlm (Kodak
Biomax MR-1, Sigma-Aldrich, UK) along with autoradio-
graphic [3H] microscale standards (GE Healthcare,
Amersham, U.K.) for 3 weeks ([3H]-AMPA) or 4 weeks
([3H]-(+)-MK801). Sections for all treatment groups were
processed in parallel and apposed to the same ﬁlm at the
same time; slides were developed and analysed in parallel
(Kitchen et al.1997); structures were identiﬁed by refer-
ence to the mouse brain atlas of Franklin & Paxinos
(2001) and analysed using an image analyser (MCID; Im-
age Research, Linton, UK). Speciﬁc binding was deter-
mined by subtracting non-speciﬁc binding from total
binding: for [3H]-AMPA labelling, non-speciﬁc binding
was homogeneous; therefore, a representative non-
speciﬁc binding area was subtracted from all total values;
for [3H]-(+)-MK801 labelling, non-speciﬁc binding was
taken from the corresponding area for each brain region
analysed.
Data analysis
All data are presented as mean ± standard error of the
mean (S.E.M). CPP data are presented as Preference
Scores for the time (seconds) spent in morphine-paired
compartment; these are calculated as time spent in
morphine-paired compartment450 (half the maximum
time, in seconds). All behavioural analyses were per-
formed using in vivo stat with a one-way ANOVAwith re-
peated measures, with post hoc analysis with Benjamini–
Hochberg test for multiple comparisons when signiﬁcant
interaction effects were observed (P < 0.05). For analysis
of the effects of intracerebral MLA, a one-way ANOVA
was performed. For analysis of autoradiographic binding,
a two-way ANOVAwith factors ‘treatment’ (saline versus
MLA) and ‘behaviour’ (saline-primed versus morphine-
primed reinstatement) was performed for each region
analysed.
RESULTS
Effect of the α7 nicotinic acetylcholine receptor
antagonist methyllycaconitine on morphine-conditioned
place preference in mice
Mice readily acquired morphine-CPP and displayed a sig-
niﬁcant preference for the compartment associated with
the morphine dose (10 mg/kg i.p.) after 4 days of condi-
tioning (Fig. S1). This could be extinguished by pairing
saline treatments with both compartments. Morphine-
CPP could be reinstated by a priming dose of morphine
(5 mg/kg i.p.) in mice that had acquired morphine-CPP
prior to extinction (Fig. S1). The conditioning and prim-
ing doses of morphine were based on previously pub-
lished studies in mice (Tzschentke 2007; Feng et al.
2011) and pilot studies to optimize priming dose.
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The involvement of α7 nAChRs in morphine-CPP was
examined by systemic administration of MLA (4 mg/kg s.
c.). This dose of MLAwas based on literature evidence for
its selectivity and efﬁcacy in mice (Feng et al. 2011). MLA
itself did not induce any CPP or aversion (MLA + saline:
habituation 3.7 ± 28.6 seconds, post conditioning
33.1 ± 40.7 seconds versus saline + saline: habituation
18.3 ± 52.9 seconds, post conditioning 16.2 ± 41.0 sec-
onds, no effect of treatment P = 0.75 or test P = 0.45,
n = 7/treatment group; data not shown).
MLA was administered at different stages of
morphine-CPP (either prior to morphine administration,
prior to testing or immediately after a morphine-
conditioned reconsolidation trial; Fig. 1a–c, respectively).
MLA given prior to morphine or saline before each condi-
tioning trial did not affect acquisition of morphine-CPP
(Fig. 1a). There was no signiﬁcant effect of treatment
(F(1,22) = 0.15, P = 0.699) but a signiﬁcant effect of test
(F(1,30) = 24.09, P = <0.001). Post hoc pairwise compar-
isons revealed signiﬁcant morphine-CPP in saline + mor-
phine group (preference score during habituation:
10.8±39.0 seconds; post-conditioning: 164.1±34.5 sec-
onds, n = 16, P = 0.012), and MLA + morphine group
(preference score during habituation: 3.2 ± 36.7 sec-
onds; post-conditioning: 179.8 ± 45.8 seconds, n = 16,
P = 0.003). There was no signiﬁcant difference between
the MLA pretreated and the saline pretreated groups
(n = 16, P = 0.69).
To assess if α7 nAChRs have any effect on the mainte-
nance and expression of morphine-CPP, mice underwent
morphine conditioning followed by a post-conditioning
preference test and were again tested for their preference
scores on the following 4 days and 1 week later. MLA
was given 20minutes before each preference test (Fig. 1b).
CPP was signiﬁcantly learned in both treatment groups:
there was a signiﬁcant effect of test (F(6,78) = 4.37,
P = 0.001, n = 12/treatment) but not of treatment
(F(1,13) = 0.78, P = 0.394). Post hoc pairwise comparisons
indicated signiﬁcant expression of morphine-CPP on pref-
erence test day 1 (saline: P = 0.004, MLA: P = 0.024,
n = 12/treatment). Preference scores declined only slowly
over time with repeated testing; importantly, there was no
signiﬁcant difference at any time-point between saline and
MLA-treated animals, showing thatMLA did not affect the
expression and maintenance of morphine-CPP.
To determine if α7 nAChRs play any role in the
reconsolidation of morphine-CPP, MLA was given imme-
diately after a reconsolidation trial (in which morphine,
10 mg/kg, was paired with the previously drug-paired
compartment; Fig. 1c). Mice were tested for their com-
partment preference 24 hours and 7 days later (Fig. 1d).
There was no signiﬁcant effect of MLA treatment
(F(1,17) = 0, P = 0.961) but a signiﬁcant effect of test
(F(2,44) = 14.25, P = <0.001, n = 12/treatment group).
Post hoc analysis revealed no signiﬁcant difference be-
tween treatment groups after 24 hours or 1 week later
indicating that MLA had no effect on reconsolidation of
morphine-induced CPP.
Next, MLA was tested on reinstatement of morphine-
CPP: mice acquired morphine-CPP which was then
extinguished by repeated saline administration in associa-
tion with both compartments of the CPP apparatus; MLA
or saline was given prior to a priming dose of morphine
(5 mg/kg) to reinstate morphine-CPP (Fig. 1c). Immedi-
ately, after receiving the priming dose, mice were tested
in the CPP apparatus for any compartment preference.
The priming dose of morphine produced a robust rein-
statement of morphine-CPP whereas prior treatment with
MLA signiﬁcantly attenuated reinstatement (Fig. 1e).
There was no signiﬁcance in the effect of treatment
(F(1,52) = 1.15, P = 0.288) but a signiﬁcant effect of test
(F(3,156) = 13.48, P = <0.001, n = 20/treatment group).
Post hoc analysis for multiple comparisons revealed that
only animals that received saline prior to the priming dose
of morphine showed signiﬁcant reinstatement (saline pref-
erence score at extinction: 42.2 ± 14.0 seconds versus
143.1 ± 33.2 seconds at reinstatement; P = 0.003; MLA
preference score at extinction: 37.3 ± 13.8 seconds versus
67.3 ± 41.7 seconds at reinstatement, P = 0.135, n = 20/
treatment group). The time spent in the drug paired side
after morphine-primed reinstatement was signiﬁcantly
different between the two treatments (P = 0.0016).
Glutamate receptor binding: effect of reinstatement of
morphine-conditioned place preference and
methyllycaconitine pretreatment
Quantitative autoradiography was used to determine the
levels of [3H]-(+)-MK801 and [3H]-AMPA binding in
brain sections prepared from the brains of mice that
had undergone reinstatement of morphine-CPP, or
saline-primed controls, with or without MLA pretreat-
ment. Sections were taken at four levels from Bregma.
Representative autoradiographs of [3H]-(+)-MK-801
binding are shown in Figure 2a. There was differential la-
belling of brain regions, with highest levels in the hippo-
campus, followed by cortical areas, in agreement with
previous reports (Bowery, Wong, & Hudson 1988). There
was no difference in speciﬁc [3H]-(+)-MK-801 binding
between treatment groups, in any of the brain regions
analysed (Fig. 2b; Table S1).
Representative autoradiographs of [3H]-AMPA bind-
ing are shown in Figure 3a. Labelling was particularly
high in cortical areas and hippocampus, but very low in
thalamic areas, as previously reported (Monaghan, Yao,
& Cotman 1984). Quantitation of speciﬁc [3H]-AMPA
binding (Fig. 3b; Table S2) revealed a signiﬁcant increase
in [3H]AMPA binding density after morphine
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reinstatement in the CA1/CA2 subregions of the ventral
hippocampus: (17.1 ± 3.3%; P < 0.05; n = 4–6/treat-
ment group). There was no signiﬁcant difference in
vCA3 or any other region analysed.
Pretreatment with MLA before morphine-primed
reinstatement resulted in signiﬁcantly lower binding in
the CA1/CA2 subregion of the ventral hippocampus
compared with values from mice that received
saline before the morphine priming dose (Treat-
ment × Behaviour interaction F(1,15) = 5.4, P < 0.05;
Fig. 3b; Table S2). MLA pretreatment of saline controls
did not affect [3H]-AMPA binding, and there were no sig-
niﬁcant differences between treatment groups in any
other region examined.
Figure 2 Effect of morphine-CPP reinstatement, in the presence and absence of MLA, on NMDA receptor binding in mouse brain. Animals
underwent morphine-CPP acquisition and extinction (Fig. 1c). A parallel set of animals followed the same procedure but received saline instead
of morphine. Each group was then randomly divided into two sets that received either saline or MLA (4 mg/kg) 20 minutes before saline or a
priming dose of morphine (5 mg/kg) and were then tested for reinstatement of morphine-CPP. Immediately afterwards, mice were killed and
brains were prepared for autoradiography as described in the Methods. Sections were labelled with 70 nM [3H]-(+)-MK801, in the absence
and presence of 1 μM (+)-MK801 to determine non-speciﬁc binding. (a) Representative computer-enhanced autoradiograms of [3H]-(+)-
MK801 binding in coronal brain sections of mice taken at four levels corresponding to prefrontal cortex (bregma 1.94 mm), striatum (bregma
1.42 mm), dorsal hippocampus (bregma1.22 mm) and the midbrain/ventral hippocampus (bregma3.08 mm; Paxinos & Frankilin 2012). Bind-
ing levels are represented using a pseudocolour interpretation of black and white ﬁlm images in fmol/mg tissue equivalent. Representative auto-
radiograms for non-speciﬁc binding (NSB) are shown (far right column). (b) Quantitative NMDA receptor binding. Levels of [3H]-(+)-MK801
binding (fmol/mg tissue equivalent) are shown for prelimbic cortex (PrL), infralimbic cortex (IL), CA1 and CA2 regions of the ventral hippocampus
combined (vCA1 + CA2), ventral hippocampus CA3 (vCA3), dorsal hippocampus CA1, CA2 and CA3 separately (dCA1, dCA2 and dCA3), for
each of the treatment groups (saline + saline control, saline + morphine-primed reinstatement, MLA + saline control, MLA + morphine-primed
reinstatement). Data are presented as mean ± S.E.M. (n = 4–7). There were no statistically signiﬁcant differences between any treatment groups in
any of the brain regions quantiﬁed
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Effect of intracerebral administration of
methyllycaconitine on reinstatement of
morphine-conditioned place preference in rats
To evaluate the central locus of action of MLA in attenu-
ating reinstatement of morphine-CPP, local administra-
tion of MLA was undertaken. Because this approach is
more appropriate for use in rats, it was necessary to ﬁrst
replicate the inhibition by systemic MLA of morphine-
primed reinstatement of CPP in this species. Male Wistar
rats underwent conditioning (morphine 5 mg/kg s.c), ex-
tinction and then received either saline or a priming dose
of morphine (2.5 mg/kg s.c) immediately before the rein-
statement trial. MLA (4 mg/kg s.c) or saline was admin-
istered 20 minutes prior to the morphine-priming dose.
Drug doses were based on previous experience (Cordery
Figure 3 Effect of morphine-CPP reinstatement, in the presence and absence of MLA, on AMPA receptor binding in mouse brain. Animals
underwent morphine-CPP acquisition and reinstatement, and their brains were prepared for autoradiography as described in the legend to
Figure 2. Sections were labelled with 10 nM [3H]-AMPA, in the absence and presence of 0.1 μM CNQX to determine non-speciﬁc binding.
(a) Representative computer-enhanced autoradiograms of [3H]-AMPA binding in coronal brain sections of mice taken at four levels corre-
sponding to prefrontal cortex (bregma 1.94 mm), striatum (bregma 1.42 mm), dorsal hippocampus (bregma 1.22 mm) and the midbrain/
ventral hippocampus (bregma 3.08 mm; Paxinos & Franklin 2012). Binding levels are represented using a pseudocolour interpretation of
black and white ﬁlm images in fmol/mg tissue equivalent. Representative autoradiograms for non-speciﬁc binding (NSB) are shown (far right
column). (b) Quantitative AMPA receptor binding. Levels of [3H]-AMPA binding (fmol/mg tissue equivalent) are shown for prelimbic cortex
(PrL), infralimbic cortex (IL), CA1 and CA2 regions of the ventral hippocampus combined (vCA1 + CA2), ventral hippocampus CA3 (vCA3),
dorsal hippocampus CA1, CA2 and CA3 separately (dCA1, dCA2, dCA3), for each of the treatment groups (saline + saline control,
saline + morphine-primed reinstatement, MLA + saline control, MLA + morphine-primed reinstatement). Data are presented as mean ±
S.E.M. (n = 4–6). *Signiﬁcantly different from saline control and from MLA-pretreated, morphine-primed condition, P < 0.05 (two-way
ANOVA)
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et al. 2014) and literature precedent (Markou & Paterson
2001; Tzschentke 2007; Aguilar et al. 2009; Liu 2014).
There was a signiﬁcant acquisition of morphine-CPP
that was extinguished and reinstated in response to mor-
phine (P = 0.007) but not saline (P = 0.34; Fig. 4a). Sys-
temic MLA signiﬁcantly inhibited the reinstatement of
morphine-primed CPP (Fig. 4b). There was no signiﬁcant
effect of treatment (F(1,49) = 0.70, P = 0.408) but a sig-
niﬁcant effect of test (F(4,176) = 3.96, P = 0.004, n = 26/
treatment group). Post hoc pairwise comparisons revealed
that only animals pretreated with saline prior to the mor-
phine priming dose signiﬁcantly reinstated (saline prefer-
ence score at extinction: 25 ± 23 seconds versus
112 ± 46 seconds at reinstatement (P = 0.007); MLA
preference score at extinction: 18 ± 23 seconds versus
35 ± 46 seconds at reinstatement, P = 0.667, n = 26/
treatment group). The time spent in the drug paired side
was signiﬁcantly different between the two treatments
(P = 0.024).
To test the effect of local delivery of MLA on
morphine-primed reinstatement of CPP, rats underwent
acquisition and extinction of morphine-CPP. Bilateral
cannulae were then implanted in the dorsal hippocam-
pus, ventral hippocampus, or mPFC. One week post sur-
gery, animals received a bilateral infusion of saline or
MLA (6.75 μg/hemisphere) 15 minutes prior to a mor-
phine priming dose (2.5 mg/kg s.c) and free access to
the CPP compartments to determine any preference. This
dose of MLA, delivered intracerebrally, has been reported
to be effective in other behavioural models (Addy,
Nakijama, & Levin 2003; Nott & Levin 2006). Prior to
surgery, there was a signiﬁcant effect of morphine-CPP
(F(2,94) = 3.38, P = 0.0381) but no signiﬁcant effect of
treatment group (F(1,47) = 0.03, P = 0.8657, n = 25/
treatment group), indicating acquisition and extinction
of morphine-CPP with no difference between the groups
that would subsequently receive local MLA or saline infu-
sions (Fig. 5). Animals that received saline intracerebrally
prior to the priming dose of morphine showed robust re-
instatement of morphine-CPP (Fig. 5). Reinstatement
was not affected by prior infusion of MLA into the dorsal
hippocampus (P = 0.82, n = 8, Fig. 5a) or mPFC
(P = 0.70, n = 8, Fig. 5c). However, MLA infused into
the ventral hippocampus abolished morphine-primed re-
instatement of CPP (P = 0.012, n = 8, saline preference
score at reinstatement: 164 ± 47 seconds versus MLA
preference score at reinstatement: 70 ± 67 seconds;
Fig. 5b). Thus, MLA delivered into the ventral hippocam-
pus, but not the dorsal hippocampus or mPFC,
completely blocks morphine-primed reinstatement of
morphine-CPP.
DISCUSSION
This study corroborates and extends a previous report
(Feng et al. 2011) that blockade of α7 nAChRs attenuates
reinstatement of morphine-primed CPP in mice. Here, we
have reproduced this ﬁnding in a different strain of mouse
Figure 4 Morphine-CPP in Wistar rats and effect of MLA on reinstatement. (a) Rats were divided into two groups, both groups underwent
acquisition and extinction of morphine-CPP (5 mg/kg morphine) as described win the Methods. Following extinction, one group received a prim-
ing dose of morphine (2.5 mg/kg) while the other group received saline (arrow). They were tested for reinstatement of morphine-CPP. Data are
presented as mean ± S.E.M. preference scores (n = 26). Morphine-primed group was signiﬁcantly different from saline controls, **P< 0.01 (one-
way ANOVA and Benjamini–Hochberg test for multiple comparisons). (b) Rats were divided into two groups, both groups underwent acqui-
sition and extinction of morphine-CPP as aforementioned. Following extinction, both groups received a priming dose of morphine (2.5 mg/kg),
but one group received MLA (4 mg/kg) prior to the priming dose while the other group received saline (arrow). They were tested for reinstate-
ment of morphine-CPP. Data are presented as mean ± S.E.M. preference scores (n = 26). Saline-pretreated morphine-primed group was
signiﬁcantly different from morphine-primed group that received MLA, *P < 0.05 (one-way ANOVA and Benjamini–Hochberg test for multiple
comparisons)
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(C57BL/6, compared with BalbC used by Feng et al.
(2011)) and extended it to Wistar rats. Further, we have
shown that α7 nAChR blockade by systemic delivery of
MLA is speciﬁc in only inhibiting the reinstatement phase
of the CPP paradigm, and that this action is reproduced
by MLA delivered into the ventral hippocampus (but not
the dorsal hippocampus or mPFC). This locus of action
of MLA accords with increases in AMPA receptor binding
in CA1/CA2 regions of the ventral hippocampus in re-
sponse to morphine-primed reinstatement that are also
attenuated by systemic MLA.
CPP provides a model of Pavlovian associative learn-
ing, in which the unconditional stimulus (drug) is paired
with a conditional stimulus (environmental context)
(Bardo & Bevins 2000; Tzschentke 2007; Aguilar et al.
2009). The ability of rodents to rapidly learn to
positively associate a distinctive chamber of the CPP
apparatus with the unconditioned stimulus, measured
as the drug-free preference score, reﬂects the incentive
salience of the drug. This associative learning has face
validity for human drug addiction in which strong
associations are formed with the context of drug taking
(Napier, Herrold, & de Wit 2013). Other aspects of drug
dependence, maintenance, reconsolidation and extinc-
tion, are also modelled in the CPP paradigm. The endur-
ance of the associative learning beyond extinction is
demonstrated by the ready reinstatement of CPP in re-
sponse to a trigger, in this case, a priming drug dose
(Aguilar et al. 2009). Reinstatement provides a useful
model relevant to relapse in abstinent addicts (Napier
et al. 2013). Relapse is a major social problem and inter-
ventions that target this aspect of drug dependency
would be advantageous.
The selective effect of MLA on morphine-primed rein-
statement is robust, as demonstrated in both mice and
rats and via two modes of delivery (systemic and intrace-
rebral). The data suggest that α7 nAChRs contribute
speciﬁcally to this phase of the addictive drug cycle.
Interestingly, a selective effect for α7 nAChRs in cue-
induced reinstatement of nicotine self-administration
has also been reported (Liu 2014). More recently,
increasing kynurenic acid (a negative modulator of
Figure 5 Effect of intracerebral administration of MLA on reinstatement of morphine-CPP in rats. Rats acquired morphine-CPP that was
extinguished prior to the implantation of bilateral intracerebral cannulae in the dorsal hippocampus (a), ventral hippocampus (b) or prefrontal
cortex (c). Animals then received either saline or MLA (6.75 μg/hemisphere) prior to a priming dose of morphine (2.5 mg/kg) (arrows) and test-
ing for reinstatement of morphine-CPP. Data are presented as mean ± S.E.M. preference scores (n = 8). In ventral hippocampus, saline
pretreated morphine-primed group was signiﬁcantly different from morphine-primed group that received MLA, *P < 0.05 (one-way ANOVA
and Benjamini–Hochberg test for multiple comparisons)
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α7 nAChRs) was found to attenuate both drug-induced
and cue-induced reinstatement of nicotine and cocaine
self-administration in squirrel monkeys (Secci et al.
2017). Evidence that this effect was mediated by α7
nAChRs was provided by the opposing action of a positive
allosteric modulator. Together, these studies support a
role for α7 nAChRs more generally in circuitry responsi-
ble for the retrieval of drug and context associated
memories. Basal forebrain cholinergic activity appears
necessary for cue-induced relapse (Pitchers et al. 2017),
and α7 nAChRs may mediate, at least in part, this cholin-
ergic signalling.
The hippocampus is a major target of cholinergic
projection neurons from the basal forebrain. α7 nAChRs
are highly expressed in the hippocampus where they can
modulate glutamate-mediated synaptic plasticity (Yakel
2014). Synaptic strengthening is correlated with an
increase in the number of synaptic AMPA (but not
N-methyl-d-aspartate) receptors (Kessels & Malinow
2009), and this may be reﬂected in the signiﬁcant
increase in [3H]-AMPA binding localized to the
CA1/CA2 area of the ventral hippocampus after
morphine-primed reinstatement. Inhibition of the
increased [3H]-AMPA binding by prior administration
of MLA (Fig. 3) suggests that α7 nAChRs play a critical
role in facilitating such synaptic changes. The ability of
MLA delivered into the ventral hippocampus (but not
other brain areas examined) to abolish morphine-primed
reinstatement links the behavioural response to α7
nAChR-mediated mechanisms in this brain region. The
ventral hippocampus is connected to circuitry related
to emotion, stress and affect; connections to the nucleus
accumbens shell, prefrontal cortex and amygdala give it
a central role in motivational learning (Fanselow &
Dong 2010).
With respect to nAChRs in addiction, most attention
has focussed on the roles of nAChR subtypes in nicotine
dependence. α4β2 nAChRs are critical in mediating the
rewarding properties of nicotine (Picciotto et al. 1998;
Pons et al. 2008) and the α4β2 nAChR-selective antago-
nist dihydroβerythroidine reduces self-administration
(Watkins et al. 1999; Grottick et al. 2000), with a locus
of action in the VTA (Corrigall et al. 1994). In contrast,
pharmacological antagonism or genetic deletion of α7
nAChRs has been reported to have no effect on nicotine
self-administration (Grottick et al. 2000; Pons et al.
2008; Liu 2014) or acquisition of nicotine-CPP (Walters
et al. 2006), although other studies have shown an atten-
uation of intravenous (Markou & Paterson 2001) or
intracranial nicotine self-administration (Besson et al.
2012), without affecting the somatic signs of nicotine
withdrawal (Markou & Paterson 2001). However,
Liu (2014) found that systemic MLA (but not
dihydroβerythroidine) selectively attenuated cue-induced
reinstatement of nicotine seeking in rats, without affect-
ing the development of nicotine self-administration.
These ﬁndings suggest distinct roles for α4β2 and α7
nAChRs in nicotine reward and relapse, respectively,
and resonate with the selective role for α7 nAChRs in
the current study, in which acquisition, maintenance
and reconsolidation of morphine-CPP were unaffected
by MLA.
In the present work, systemically administered MLA
substantially attenuated morphine-primed reinstatement
of CPP whereas delivery of MLA into the ventral hippo-
campus completely abolished the response. This could re-
ﬂect a bigger local dose effect intracerebrally that fully
antagonized α7 nAChRs, whereas the systemic dose of
4 mg/kg might be suboptimal. Indeed Liu (2014) found
a signiﬁcant dose effect of MLA at 2.5 and 10 mg/kg for
inhibition of reinstatement of cue-induced nicotine self-
administration in rats. However, high doses of MLA run
the risk of also antagonizing other nAChR subtypes (no-
tably α6β2 nAChRs) because this antagonist is selective
rather than speciﬁc for α7 nAChRs (Mogg et al. 2002).
The negligible level of α6-containing nAChRs in the
hippocampus supports a speciﬁc action of MLA at α7
nAChRs in the ventral hippocampus. An alternative ex-
planation of the greater efﬁcacy of locally administered
MLA is that α7 nAChRs may exert opposing inﬂuences
in other brain regions such as the PFC (Bloem, Poorthuis,
& Mansvelder 2014; Udakis et al. 2016) that temper
the profound antagonism mediated by the ventral
hippocampus.
This study provides evidence for a selective role for α7
nAChRs in the ventral hippocampus in the reinstatement
of morphine-primed CPP, which encourages further in-
vestigation of α7 nAChRs as potential targets for
preventing opiate relapse. α7 nAChRs appear to play a
similar role in nicotine reinstatement (Liu 2014) and
have been implicated in cocaine reinstatement (Secci
et al. 2017). Therefore, an α7 nAChR-mediated mecha-
nism may contribute to the reinstatement of drug seeking
more generally in abstinent addicts.
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Table S1. Speciﬁc [3H]-(+)-MK801 binding to sections of
mouse brain after reinstatement of morphine-CPP, or
saline–primed controls, with or without pre-treatment
with MLA (4 mg/kg s.c.). Sections were processed and
analysed as described in the Methods (Kitchen et al.
1997). Data are the mean ± S.E.M. from 5-6 animals.
Cortical regions: Prelimbic (PrL), Infralimbic (IL), Motor
(M1-2), Cingulate (CgCx), Auditory (AuCx) and visual
(ViCx); Caudate putamen (CPu), Accumbens shell (Acbs)
and core (Acbc), Dorsal Hippocampus CA1-3 (dCA1,
dCA2, dCA3), Central Amygdala (CeA), Basolateral
Amygdala (BLA), and Basomedial (BMA) nuclei of the
Amygdala, Ventral Hippocampus CA1-3 (vCA1, vCA2,
vCA3), Ventral Tegmental Area (VTA).
Table S2. Speciﬁc [3H]-AMPA binding to sections of
mouse brain after reinstatement of morphine-CPP, or sa-
line–primed controls, with or without pre-treatment with
MLA (4 mg/kg s.c.). Sections were processed and
analysed as described in the Methods (Kitchen et al.
1997). Data are the mean ± S.E.M. from 5-6 animals.
Cortical regions: Prelimbic (PrL), Infralimbic (IL), Motor
(M1-2), Cingulate (CgCx), Auditory (AuCx) and visual
(ViCx); Caudate putamen (CPu), Accumbens core (Acbc)
and shell (Acbs), Basomedial nuclei of the Amygdala
(BMA), Central Amygdala (CeA), Basolateral Amygdala
(BLA); Dorsal Hippocampus CA1-3 (dCA1, dCA2,
dCA3), and Ventral Hippocampus CA1-3 (vCA1 + CA2,
vCA3), Ventral Tegmental Area (VTA).
Figure S1. Morphine-CPP in mice. The ability of mor-
phine to induce CPP was compared with saline-treated
mice, in protocols analogous to the schematics in Figure
1. A. Acquisition of morphine-CPP. Animals were habitu-
ated to the CPP apparatus on 2 consecutive days and
pseudo-randomly assigned to two groups with similar
mean preference scores. Mice given morphine (10
mg/kg) or saline on 4 consecutive days, in alternate
compartments, displayed a robust preference for the
morphine-paired compartment (***p<0.001, n=12/
treatment group). Mice that received saline in both
compartments displayed no preference. B. Extinction
and reinstatement of morphine-CPP. Mice were pseudo-
randomly assigned to two groups and both groups ac-
quired morphine-CPP, which was then extinguished fol-
lowing 4 days of pairing saline injections with the
previously morphine-paired compartment (see Figure
1C). One group (black bars) then received a priming
dose of morphine (5 mg/kg) and displayed a robust rein-
statement of preference for the morphine-paired com-
partment. The control group that received saline at
this stage did not reinstate (morphine-primed preference
score: 150.0±29.1 seconds, saline-primed preference
score: -13.7±56.6 seconds in previously morphine-
paired compartment, ***p<0.001, n=10-12/treatment
group).
Figure S2. A schematic diagram illustrating the distribu-
tion of bilateral injection cannula placements. To verify
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cannula placements, at the end of each experiment rats
were killed by rising CO2 asphyxiation and 0.5 μl brilliant
blue dye was infused via each cannula. Coronal sections
were taken from rats that had previously been given sa-
line prior to morphine-primed CPP reinstatement (A)
and rats given MLA prior to morphine-primed CPP rein-
statement (B). Regions of dye infusion were compared
with a brain atlas (Paxinos & Watson 2007). Black dots
indicate cannulae placements in individual animals.
Smaller red dots indicate target coordinates.
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